Trademark: IRAP 1018197
Word
IRAP
ID
1018197
Trademark Type
Word
Status
Protected: Expired renewal possible
Application Date
27 March 2004
Registration Date
27 March 2004
Renewal Date
27 March 2024
Owner(s)
Service
Refer to WIPO address for Correspondence
Goods and Services:
Class 5:
Pharmaceutical and veterinary products and preparations, in particular sanitary preparations; cytokine and preparations containing cytokine, in particular for treating diseases of the locomotor system and of the nervous system; natural medicinal substances, in particular for treating diseases of the locomotor system and of the nervous system; medicines and kits for the treatment and diagnosis of illness, in particular diseases of the locomotor system and of the nervous system, in particular genetic tests for osteoporosis and test for rheumatism; DNA-based diagnostics for rheumatoid diseases and diseases of the locomotor system and of the nervous system; affinity purifying kits, kits for conducting gene therapy, immunocytology kits, polymerase chain reaction (PCR) kits; microorganisms, plasmids, cultures of microorganisms, the aforementioned products for medical and/or pharmaceutical and/or veterinary purposes; DNA sequences, cloning vectors, monoclonal and polyclonal antibodies; cell culture systems for diagnostic and therapeutic purposes; cells cultivated in vitro, in particular cartilage cells for treating defects; chemicals for in vitro analysis; purified enzymes, semi-purified enzymes and biochemical reagents, the aforementioned products for medical and/or pharmaceutical and/or veterinary purposes; purified recombinations and natural proteins, cell growth additives, the aforementioned products for medical and/or pharmaceutical and/or veterinary purposes
Pharmaceutical and veterinary products and preparations, in particular sanitary preparations; cytokine and preparations containing cytokine, in particular for treating diseases of the locomotor system and of the nervous system; natural medicinal substances, in particular for treating diseases of the locomotor system and of the nervous system; medicines and kits for the treatment and diagnosis of illness, in particular diseases of the locomotor system and of the nervous system, in particular genetic tests for osteoporosis and test for rheumatism; DNA-based diagnostics for rheumatoid diseases and diseases of the locomotor system and of the nervous system; affinity purifying kits, kits for conducting gene therapy, immunocytology kits, polymerase chain reaction (PCR) kits; microorganisms, plasmids, cultures of microorganisms, the aforementioned products for medical and/or pharmaceutical and/or veterinary purposes; DNA sequences, cloning vectors, monoclonal and polyclonal antibodies; cell culture systems for diagnostic and therapeutic purposes; cells cultivated in vitro, in particular cartilage cells for treating defects; chemicals for in vitro analysis; purified enzymes, semi-purified enzymes and biochemical reagents, the aforementioned products for medical and/or pharmaceutical and/or veterinary purposes; purified recombinations and natural proteins, cell growth additives, the aforementioned products for medical and/or pharmaceutical and/or veterinary purposes
Class 10:
Orthopaedic articles, in particular ortheses which can be filled with therapeutic substances or to which such substances can be added; apparatus for evaluating in vitro and vivo diagnostic tests for medical purposes on the basis of blood samples; artificial limbs and endoprostheses; syringes
Orthopaedic articles, in particular ortheses which can be filled with therapeutic substances or to which such substances can be added; apparatus for evaluating in vitro and vivo diagnostic tests for medical purposes on the basis of blood samples; artificial limbs and endoprostheses; syringes
Class 42:
Scientific and industrial research, in particular the development of PCR tests, immunological tests of bone metabolism parameters and of cell culture systems for diagnostic and therapeutic purposes; commissioned research with regard to metabolic diseases of the locomotor system; development of DNA-based diagnostics for rheumatoid diseases and diseases of the locomotor system, in particular arthrosis, multiple sclerosis and diseases of bone metabolism and of the nervous system; cloning and expression of genes, testing the effect of substances, including natural substances, for the disease-relevant parameters for diseases of the locomotor system and of the nervous system; development of gene therapies for rheumatism, autoimmune diseases, arthrosis, nerve diseases, bone diseases and nervous system diseases; development of cytokine and preparations containing cytokine for treating diseases of the locomotor system and of the nervous system; cultivation of cells in vitro, in particular for treating defects and for preparing homologous preparations containing cytokine
Scientific and industrial research, in particular the development of PCR tests, immunological tests of bone metabolism parameters and of cell culture systems for diagnostic and therapeutic purposes; commissioned research with regard to metabolic diseases of the locomotor system; development of DNA-based diagnostics for rheumatoid diseases and diseases of the locomotor system, in particular arthrosis, multiple sclerosis and diseases of bone metabolism and of the nervous system; cloning and expression of genes, testing the effect of substances, including natural substances, for the disease-relevant parameters for diseases of the locomotor system and of the nervous system; development of gene therapies for rheumatism, autoimmune diseases, arthrosis, nerve diseases, bone diseases and nervous system diseases; development of cytokine and preparations containing cytokine for treating diseases of the locomotor system and of the nervous system; cultivation of cells in vitro, in particular for treating defects and for preparing homologous preparations containing cytokine